Patents by Inventor Dag-Eirik Ramsoy

Dag-Eirik Ramsoy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9956245
    Abstract: The present invention relates to a gel composition comprising a glucan and a gelling agent, said composition having a melting point (gel to sol) above 37° C., as well as to the uses of this composition in therapy, in particular in wound healing.
    Type: Grant
    Filed: November 29, 2011
    Date of Patent: May 1, 2018
    Assignee: BIOTECH PHARMACON ASA
    Inventors: Rolf Engstad, Dag-Eirik Ramsøy, Erik Steene
  • Patent number: 9750688
    Abstract: The present invention relates to a glucan having a weight average molar mass of 15,000 to 50,000 g/mol on a single chain basis and a weight average molar mass in aqueous solution on an aggregate basis of 4 to 20×105 g/mol and existing in gel form in aqueous solution at a concentration ?1% at 25° C. and neutral pH and having a melting temperature (gel to sol) of 35 to 60° C. when the glucan is dissolved in water at a concentration of 2%, methods for the production thereof, medical uses thereof, physical supports having the glucan applied thereto or impregnated thereon and in vitro methods of proliferation of skin cells which comprise contacting a population of skin cells with the glucan.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: September 5, 2017
    Assignee: BIOTEC PHARMACON ASA
    Inventors: Rolf Engstad, Stein-Tore Solem, Dag-Eirik Ramsøy
  • Publication number: 20160256385
    Abstract: The present invention relates to a glucan having a weight average molar mass of 15,000 to 50,000 g/mol on a single chain basis and a weight average molar mass in aqueous solution on an aggregate basis of 4 to 20×105 g/mol and existing in gel form in aqueous solution at a concentration ?1% at 25° C. and neutral pH and having a melting temperature (gel to sol) of 35 to 60° C. when the glucan is dissolved in water at a concentration of 2%, methods for the production thereof, medical uses thereof, physical supports having the glucan applied thereto or impregnated thereon and in vitro methods of proliferation of skin cells which comprise contacting a population of skin cells with the glucan.
    Type: Application
    Filed: March 10, 2016
    Publication date: September 8, 2016
    Applicant: BIOTEC PHARMACON ASA
    Inventors: Rolf Engstad, Stein-Tore Solem, Dag-Eirik Ramsøy
  • Patent number: 9314432
    Abstract: The present invention relates to a glucan having a weight average molar mass of 15,000 to 50,000 g/mol on a single chain basis and a weight average molar mass in aqueous solution on an aggregate basis of 4 to 20×105 g/mol and existing in gel form in aqueous solution at a concentration ?1% at 25° C. and neutral pH and having a melting temperature (gel to sol) of 35 to 60° C. when the glucan is dissolved in water at a concentration of 2%, methods for the production thereof, medical uses thereof, physical supports having the glucan applied thereto or impregnated thereon and in vitro methods of proliferation of skin cells which comprise contacting a population of skin cells with the glucan.
    Type: Grant
    Filed: November 29, 2011
    Date of Patent: April 19, 2016
    Assignee: BIOTEC PHARMACON ASA
    Inventors: Rolf Engstad, Stein-Tore Solem, Dag-Eirik Ramsøy
  • Publication number: 20130315979
    Abstract: The present invention relates to a glucan having a weight average molar mass of 15,000 to 50,000 g/mol on a single chain basis and a weight average molar mass in aqueous solution on an aggregate basis of 4 to 20×105 g/mol and existing in gel form in aqueous solution at a concentration ?1% at 25° C. and neutral pH and having a melting temperature (gel to sol) of 35 to 60° C. when the glucan is dissolved in water at a concentration of 2%, methods for the production thereof, medical uses thereof, physical supports having the glucan applied thereto or impregnated thereon and in vitro methods of proliferation of skin cells which comprise contacting a population of skin cells with the glucan.
    Type: Application
    Filed: November 29, 2011
    Publication date: November 28, 2013
    Applicant: Biotec Pharmacon ASA
    Inventors: Rolf Engstad, Stein-Tore Solem, Dag-Eirik Ramsøy
  • Publication number: 20130309286
    Abstract: The present invention relates to a gel composition comprising a glucan and a gelling agent, said composition having a melting point (gel to sol) above 37° C., as well as to the uses of this composition in therapy, in particular in wound healing.
    Type: Application
    Filed: November 29, 2011
    Publication date: November 21, 2013
    Applicant: BIOTEC PHARMACON ASA
    Inventors: Rolf Engstad, Dag-Eirik Ramsoy, Erik Steene